Open AccessObjective Real-World Outcomes of Patients Suffering from Painful Neurogenic Claudication Treated with the mild® Procedure: Interim 6-Month Report of a Randomized Controlled Trial
Author(s) -
Timothy R Deer,
Christopher Kim,
Sayed Wahezi,
Huaguang Qu,
Dawood Sayed
Publication year - 2021
Publication title -
journal of pain research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.888
H-Index - 49
ISSN - 1178-7090
DOI - 10.2147/jpr.s312573
Subject(s) - medicine , neurogenic claudication , randomized controlled trial , lumbar spinal stenosis , incidence (geometry) , surgery , epidural steroid injection , adverse effect , interim analysis , lumbar , low back pain , optics , physics , alternative medicine , pathology
Lumbar spinal stenosis (LSS) is a serious degenerative condition of the spine that can cause significant functional disability. Therapies for these patients generally begin with conservative management, since more invasive interventions such as open surgery and spinal implants are associated with higher complication rates. Early in the treatment algorithm for LSS patients, multiple conventional medical management (CMM) therapies are often combined as an initial low-risk treatment strategy. This composite first-line treatment plan may include conservative care together with early interventional treatment options such as epidural steroid injections, radiofrequency ablation and the mild ® Procedure.